Match Document Document Title
DE10222632B4 Microsatellite markers for genetic analysis and to distinguish it from roses  
oligonucleotides microsatellite markers of Rose genome characterized by the following sequences:
DE102004045332B3 Process and assembly to elute single and twin-strand nucleic acids from a sample substrate substance in the presence of a bivalent metal ion  
A process insulates and separates single and twin-strand nucleic acids from a sample substrate substance. The twin-stranded nucleic acids are eluted with a first elution solution and the...
DE10040380B4 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties  
Use of perfluoroalkylated metal complexes (I), having a critical micelle formation concentration of less than 1 mM, a hydrodynamic micelle diameter of more than 1 nm and a proton relaxivity in...
DE102004040168A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis)  
Glucopyranosyl-substituted benzene derivatives (I) and their tautomers, sterioisomers andsalts are new. Glucopyranosyl-substituted benzene derivatives of formula (I) and their tautomers,...
DE19911504B4 A process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds  
process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds in aqueous Phase, characterized in that the oxidation catalytic using a noble metal catalyst, the precious...
DE102004039096A1 New D-xylopyranosyl-phenyl-substituted cycle compounds useful for treating e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis  
D-xylopyranosyl-phenyl-substituted cycle compounds, their tautomers, stereoisomers, mixtures and salts are new. D-xylopyranosyl-phenyl-substituted cycle compounds of formula (I), their tautomers,...
DE19628454B4 Rhamnolipid alginate complex microbiological process for its production, rhamnolipid alginate complex compositions and their uses  
Rhamnolipid alginate complex from blocks of structures obtainable by a microbiological Method for generating a fermentation rhamnolipid alginate complexes capable Bacteria of the genus...
DE102004034849A1 A process for preparing oat husks for xylan production  
According to the invention is a Oat husks for xylan production having the step oat hulls by roughen a roll mill in its surface, wherein the coating layer partially destroyed the oat hulls , while...
DE102004034474A1 Apparatus and method for efficient isolation of nucleic acids  
The This invention relates to an apparatus and a method for the efficient purification of nucleic acids and a kit for carrying out this Process.
DE102004032823A1 New D-xylopyranosyl-substituted phenyl compounds are sodium-dependent glucose cotransporter inhibitors useful to prevent or treat e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis  
D-Xylopyranosyl-substituted phenyl compounds (I) and tautomers and/or stereoisomers and salts are new. D-Xylopyranosyl-substituted phenyl compound of formula (I) and tautomers and/or stereoisomers...
DE10258007B4 Aromatic Fluorglycosidderivate, medicaments containing these compounds and methods for making these medicines  
compounds of formula I, which mean R1, R2 OH, F or H; R3 OH or F, where one of R1, R2, R3 F must be; AO, NH, CH2, S or a Binding; R4, R5, R6 hydrogen, F, Cl, Br, I, OH, CF3, NO2, CN, COOH, CO...
DE102004031588A1 Using Äpfelsäureglucosiden as flavorings  
described the use of a Äpfelsäureglucosids [2- (glucosyl) -butan-1,4-dioic acid] or a physiologically salt of a akzeptalen Äpfelsäureglucosids as a flavoring, particularly as umami flavor and...
DE20122459U1 In situ hybridization of labeled oligonucleotide to antibody light chain sequence, useful for diagnosis of e.g. allergic, autoimmune and oncogenic diseases, in presence of formamide-free buffer  
In the in situhybridization of at least one labeled oligonucleotide (ON) to detect a sequence (I) that encodes the light chain of an immunoglobulin, the new feature is that contact between the ON...
DE10258008B4 Heterocyclic Fluorglycosidderivate, medicaments containing these compounds and methods for making these medicines  
compounds of formula I, which mean R1, R2 OH, F or H; R3 OH or F, where one of R1, R2, R3 F must be; AO, NH, CH2, S or a Binding; X is O, S or optionally substituted with R6 N, in the case X = O...
DE102004034690A1 Methylidene-D-xylopyranosyl and oxo-D-xylopyranosyl-substituted phenyls, medicaments containing these compounds, their use and processes for their preparation  
D-xylopyranosyl-substituted phenyls of the general formula I, wherein the radicals R1 to R5, X, Z and R7a, R7b, R7c are as defined in claim 1, having an inhibitory effect on the sodium-dependent...
DE102004034433A1 A process for the purification and isolation of nucleic acids using cationic detergents  
The This invention relates to a method for purification and isolation of nucleic acids using cationic detergents of the general formula (I):Y+R1R2R3R4X-.whereinY is nitrogen or phosphorus,R1, R2,...
DE10015797B4 Multiplex analysis of DNA mixtures by means of photolytically readable DNA chips  
process to mass spectroscopic analysis of nucleic acids by means of a spatially defined Oligonucleotide chip, or array, characterized in that a complex Mixture of sequences is investigated...
DE202005016250U1 Topiramate and pharmaceutical formulations thereof  
topiramate characterized in that it is present in highly pure form and at least 90% of the particles have a particle size of ≤ 250 microns.
DE10231659B4 Composition for binding nucleic acid to a solid phase  
composition for binding of nucleic acids in aqueous solution to a solid phase containing a guanidinium salt, a buffering agent and a detergent, characterized in that the pH value of the solution...
DE19961182B4 Galactomannan oligosaccharides and processes for their preparation and their use  
process for the production of mannose and galactose-containing oligosaccharides from galactomannans of guar gum, wherein an aqueous solution or suspension of guar gum prepared using a bacteria of...
DE102004031116A1 Method of finding relevant substances pain using pain-relevant proteins  
The Invention relates to a method for discovering pain-related Substances using the proteins KIAA0378, BAB31214 / Q9BU64, OPA1 / KIAA0567, CPG2 / KIAA1756, LETM1, PID12832121 / FLJ20420 and PGRL...
DE102004028778A1 An oligopeptide, useful for controlling the biological activity of cellular biomolecules, comprising at least one cysteine residue and two alpha helical zones  
An oligopeptide comprising at least one cysteine residue and two alpha helical zones which flank a sequence pattern with the amino acid sequence (I) given in the specification, is new. An...
DE102004028241B4 New fluoroglycoside derivatives of pyrazoles, pharmaceutical compositions containing them and the preparation of these drugs  
compounds of formula I, which mean R1 and R2 independently of one another, F or H, where one of the radicals R1 or R2 must be F; A O, NH, CH2, S or a bond; R3 Hydrogen, F, Cl, Br, I, OH, CF3, NO2,...
DE102004028241A1 New fluoroglycoside derivatives of pyrazoles, pharmaceutical compositions containing them and their use  
The Invention relates to substituted fluoroglycoside derivatives of pyrazoles of formula I, wherein the radicals given the have meanings, and their physiologically tolerable Salts and processes...
DE60202483T2 METHOD FOR PRODUCING L-RIBAVIRIN  
A process for the preparation of ribavirin on an industrial scale is described which comprises the reaction of glycosylation of 3-substituted triazoles in the presence of a Lewis acid. Said...
DE102004022574A1 Pharmaceutical formulation, for use in inflammatory disorders, identifies the rabies virus protein P as an interferon antagonist with substitution of the P-coded nucleic acid sequence  
Identification of the rabies virus phosphor protein P as an interferon (IFN) antagonist, comprising altering the host spectrum of rhabdo viruses, to modulate the IFN response for the treatment of...
DE10120798B4 A method for determining the gene expression  
process for the analysis of gene expression in which single gene providing one the gene products with a uniform or several different primers in the form of gene primer hybridization products on a...
DE29825173U1 Fludarabine phosphate purification by precipitation from aqueous acetone as stable metal salt, useful as cytotoxic drug  
Fludarabine phosphate (FAP) is purified by treating an aqueous solution of crude FAP with base, precipitating the obtained metal salt (I) of FAP with acetone and treating (I) with acid....
DE19605657B4 Human proinsulin derivative-encoding DNA, DNA containing expression vector, transformed with this microorganism and use of this human Proinsulinderivats  
Mensc hliches Proinsulin derivative of the formula (I): B chain-ZA-chain (I)wherein: the A- and B-chains are human insulin chains respectively; Z a Peptide of formula UUXPJ- (X ') is Nuu; U an...
DE19603788B4 Active extract of devil's claw root, these containing human or veterinary medicinal preparation, method for producing a highly concentrated extract of Radix Harpagophyti or Herba and Radix Scrophularia and also its use  
drug extract of devil's claw root, available by a method in which a crude aqueous extract of Radix Harpagophyti is brought into contact with a non-ionic adsorbent resin and active substances...
DE102004027196A1 Crystallization of polymers (e.g. polyolefin, polyamide and polyurethane) and biopolymers (e.g. starch, chitin and nucleotide) comprises the utilization of an ionic fluid  
Crystallization of polymers (a) and biopolymers (b) comprising the utilization of one or more solvents, which is an ionic fluid, is new.
DE102004026494A1 Detecting specific nucleic acid comprises hybridizing peptide nucleic acid oligomer and DNA oligo where both sequences are complementary to the target and measuring fluorescent change upon mixing with target sequence which displaces oligo  
Detecting nucleic acid (I) having a predetermined sequence comprises: (a) preparing a PNA (peptide nucleic acid) oligomer (II), complementary to (I) and able to hybridize to it; (b) preparing a...
DE102004025710A1 A process for the taxon cell identification and cell sorting on gram-positive bacteria and devices therefor  
The This invention relates to a process for the taxon Cell identification and / or cell sorting on gram-positive bacteria. About that addition, the present invention provides a kit for identifying...
DE102004023906A1 A process for the production of chemical microarrays  
It is a method of producing a microarray, the microarray itself as well as the use of the microarray for the detection of interactions between probe molecules and analyte molecules from a sample...
DE10120797B4 A process for the analysis of nucleic acid chains  
process for highly parallel sequence analysis of nucleic acid sequences or nucleic acid chains (NACs), in which Fragments (NACFs) single NACs with a length produced from about 50 to 1000...
DE10221091B4 SECM for detecting nucleic acid oligomer hybridization events  
process for detecting nucleic acid oligomer hybridization events comprising the steps of a) providing a modified Surface, the modification consisting in the attachment of at least one kind...
DE102004024364A1 A process for the preparation of polymers  
The This invention relates to a process for the stepwise synthesis of polymers, in particular biopolymers on a solid support surface, comprising the steps of providing a solid support surface...
DE19932216B4 Particles, in particular microparticles or nanoparticles of crosslinked monosaccharides and oligosaccharides, a process for their preparation and use of the particles as a cosmetic agent or for the preparation of pharmaceutical compositions or food compositions  
process for the manufacture of particles, at least on the surface of a have wall of one or more monosaccharide (s) or Oligosaccharide (s) formed with at least one primary alcohol group is prepared...
DE102004046010B3 Reaction of amino alcohols with acid, organic substrates in the manner of a Mitsunobu reaction  
The Invention relates to a process for the direct conversion of an amino alcohol, of at least one hydroxyl function and at least one amino function and being provided with an organic compound as a...
DE102004025195A1 A process for preparing alkyl glycosides  
object The invention provides a process for the preparation of alkyl polyglycosides from monomeric glycosides, oligo- or polyglycosides and alcohols, according to the general scheme(Glyc-O)zH +...
DE102004023187A1 Identifying surface-associated antigens for tumor diagnosis and therapy  
According to the invention were Tumor-associated gene products expressed and coding the for nucleic acids identified. The present invention relates to the therapy and Diagnosis of diseases in...
DE10150121B4 Real time detection of DNA amplification  
process to perform a Nukleinsäureamplifikaktion, in which transcribed in a single step reaction RNA reverse, without a Inhibiting reverse transcription occurs to the formed complementary DNA...
DE4205306B4 Acid amides, drugs with the same and method for the preparation of acid amides  
amides of the general formula (I) ' in which R '1 and R '2 equal or different and are Hydrogen or füir straight-chain or branched alkyl having up to 4 carbon atoms to stand, R '3 represents...
DE102004021707A1 A process for the isolation of specific molecules that bind with high selectivity to selected target molecules  
The This invention relates to a process for isolating specific molecules highly selective to selected target molecules tie. In particular, by displacement with a specific Competitor binding...
DE4396846B4 A process for isomerizing a compound having aldose structure into a compound having ketose structure  
process of isomerizing a compound having an aldose structure into a Compound having a ketose using a organogermanium, represented by the formula (II) is represented. where R1. R2 and R3, the same...
DE10393431T5 Microarrays with more oligonucleotides in each Array Features  
Microarray, comprising a plurality of features, each of the features single-stranded oligonucleotides comprising, at least some of the features of more oligonucleotides comprising as a sequence...
DE10347710A1 Recombinant vaccines and their use  
The This invention relates to fusion molecules of antigens, the nucleic acids coding therefor, and the use of such fusion molecules and nucleic acids. Especially the invention relates to fusion...
DE10262005B4 Food, beverages, sweeteners and pharmaceuticals, as well as compositions comprising condensed Palatinose in hydrogenated form  
vital or luxury food containing hydrogenated condensed Palatinose.
DE102004019098A1 Caging Groups  
The This invention relates to novel nucleoside derivatives of the general Formula I, where R1 equal H, halogen, NO2, CN, OCH3. an alkyl, alkoxy or alkoxyalkyl group having 1 to 4 carbon atoms,...
DE102004017369A1 Screening method for the identification of PUFA-PKS in sample  
The Invention describes a method for quick and easy identification of PUFA PKS in microorganisms. It is characterized by a in vitro propagation of DNA segments specific for PUFA (polyunsaturated...